Tsou HH - Search Results

1

CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer.

Wang SC, Ho IK, Tsou HH, Tian JN, Hsiao CF, Chen CH, Tan HK, Lin L, Wu CS, Su LW, Huang CL, Yang YH, Liu ML, Lin KM, Chen CY, Liu SC, Wu HY, Chan HW, Tsai MH, Lin PS, Liu YL. Wang SC, et al. Among authors: tsou hh. J Clin Psychopharmacol. 2011 Aug;31(4):463-9. doi: 10.1097/JCP.0b013e318222b5dd. J Clin Psychopharmacol. 2011. PMID: 21694616 Clinical Trial.

2

Use of prior information for Bayesian evaluation of bridging studies.

Hsiao CF, Hsu YY, Tsou HH, Liu JP. Hsiao CF, et al. Among authors: tsou hh. J Biopharm Stat. 2007;17(1):109-21. doi: 10.1080/10543400601001501. J Biopharm Stat. 2007. PMID: 17219758

3

Mixed noninferiority margin and statistical tests in active controlled trials.

Tsou HH, Hsiao CF, Chow SC, Yue L, Xu Y, Lee S. Tsou HH, et al. J Biopharm Stat. 2007;17(2):339-57. doi: 10.1080/10543400601183861. J Biopharm Stat. 2007. PMID: 17365228

4

Translation in different diagnostic procedures---traditional Chinese medicine and Western medicine.

Hsiao CF, Tsou HH, Wu YJ, Lin CH, Chang YJ. Hsiao CF, et al. Among authors: tsou hh. J Formos Med Assoc. 2008 Dec;107(12 Suppl):74-85. doi: 10.1016/s0929-6646(09)60011-5. J Formos Med Assoc. 2008. PMID: 19129048 Free article.

5

Sample size determination for a specific region in a multiregional trial.

Ko FS, Tsou HH, Liu JP, Hsiao CF. Ko FS, et al. Among authors: tsou hh. J Biopharm Stat. 2010 Jul;20(4):870-85. doi: 10.1080/10543401003618900. J Biopharm Stat. 2010. PMID: 20496211

6

Proposals of statistical consideration to evaluation of results for a specific region in multi-regional trials--Asian perspective.

Tsou HH, Chow SC, Lan KK, Liu JP, Wang M, Chern HD, Ho LT, Hsiung CA, Hsiao CF. Tsou HH, et al. Pharm Stat. 2010 Jul-Sep;9(3):201-6. doi: 10.1002/pst.442. Pharm Stat. 2010. PMID: 20568264

7

ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment.

Lin KM, Chiu YF, Tsai IJ, Chen CH, Shen WW, Liu SC, Lu SC, Liu CY, Hsiao MC, Tang HS, Liu SI, Chang LH, Wu CS, Tsou HH, Tsai MH, Chen CY, Wang SM, Kuo HW, Hsu YT, Liu YL. Lin KM, et al. Among authors: tsou hh. Pharmacogenet Genomics. 2011 Apr;21(4):163-70. doi: 10.1097/FPC.0b013e32833db216. Pharmacogenet Genomics. 2011. PMID: 20859246

8

CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine.

Lin KM, Tsou HH, Tsai IJ, Hsiao MC, Hsiao CF, Liu CY, Shen WW, Tang HS, Fang CK, Wu CS, Lu SC, Kuo HW, Liu SC, Chan HW, Hsu YT, Tian JN, Liu YL. Lin KM, et al. Among authors: tsou hh. Pharmacogenomics. 2010 Nov;11(11):1535-43. doi: 10.2217/pgs.10.128. Pharmacogenomics. 2010. PMID: 21121774 Clinical Trial.

9

A consistency approach to evaluation of bridging studies and multi-regional trials.

Tsou HH, Chien TY, Liu JP, Hsiao CF. Tsou HH, et al. Stat Med. 2011 Jul 30;30(17):2171-86. doi: 10.1002/sim.4251. Epub 2011 May 17. Stat Med. 2011. PMID: 21590701

10

Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients.

Chen CH, Wang SC, Tsou HH, Ho IK, Tian JN, Yu CJ, Hsiao CF, Chou SY, Lin YF, Fang KC, Huang CL, Su LW, Fang YC, Liu ML, Lin KM, Hsu YT, Liu SC, Chen ACh, Liu YL. Chen CH, et al. Among authors: tsou hh. Pharmacogenomics. 2011 Oct;12(10):1397-406. doi: 10.2217/pgs.11.103. Epub 2011 Sep 8. Pharmacogenomics. 2011. PMID: 21902501

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters